BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mukaida N, Nakamoto Y. Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma. World J Gastroenterol 2018; 24(17): 1839-1858 [PMID: 29740200 DOI: 10.3748/wjg.v24.i17.1839]
URL: https://www.wjgnet.com/1007-9327/full/v24/i17/1839.htm
Number Citing Articles
1
Wenjie Han, Ning Li, Jun Liu, Yongchen Sun, Xi Yang, Yu Wang. MicroRNA-26b-5p enhances T cell responses by targeting PIM-2 in hepatocellular carcinomaCellular Signalling 2019; 59: 182 doi: 10.1016/j.cellsig.2018.11.011
2
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progressionWorld Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
3
Neda Minaei, Roya Ramezankhani, Atena Tamimi, Abbas Piryaei, Ali Zarrabi, Amir Reza Aref, Ebrahim Mostafavi, Massoud Vosough. Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near futureEuropean Journal of Cell Biology 2023; 102(1): 151284 doi: 10.1016/j.ejcb.2022.151284
4
Yue Shi, Xiaoping Men, Xueting Li, Zhicun Yang, Hongjuan Wen. Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinomaInternational Immunopharmacology 2020; 82: 106351 doi: 10.1016/j.intimp.2020.106351
5
Jia-Xi Mao, Wen-Yuan Guo, Meng Guo, Cong Liu, Fei Teng, Guo-Shan Ding. Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patientsHepatology International 2020; 14(3): 347 doi: 10.1007/s12072-020-10022-4
6
Jianing Ma, Yuning Xin, Qiang Wang, Lijuan Ding. Roles of cGAS-STING Pathway in Radiotherapy Combined with Immunotherapy for Hepatocellular CarcinomaMolecular Cancer Therapeutics 2024; 23(4): 447 doi: 10.1158/1535-7163.MCT-23-0373
7
Pil Soo Sung, Jeong Won Jang. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical ImplicationsInternational Journal of Molecular Sciences 2018; 19(11): 3648 doi: 10.3390/ijms19113648
8
Hui Wei, Jing Yang, Xia Chen, Mengxiao Liu, Huiyun Zhang, Weiming Sun, Yuping Wang, Yongning Zhou. BAIAP2L2 is a novel prognostic biomarker related to migration and invasion of HCC and associated with cuprotosisScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35420-0
9
Mohammed Abdul-Latif, Katherine Townsend, Charles Dearman, Kai-Keen Shiu, Khurum Khan. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectivesCancer Treatment Reviews 2020; 88: 102030 doi: 10.1016/j.ctrv.2020.102030
10
Reza Mahjub, Sukhdeep Jatana, Suen Ern Lee, Zhu Qin, Griffin Pauli, Meysam Soleimani, Soheil Madadi, Shyh-Dar Li. Recent advances in applying nanotechnologies for cancer immunotherapyJournal of Controlled Release 2018; 288: 239 doi: 10.1016/j.jconrel.2018.09.010
11
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary CancersTrends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
12
Mingzhen Zhou, Baorui Liu, Jie Shen. Immunotherapy for hepatocellular carcinomaClinical and Experimental Medicine 2022; 23(3): 569 doi: 10.1007/s10238-022-00874-5
13
Tanja Gerlza, Christina Trojacher, Nikola Kitic, Tiziana Adage, Andreas J. Kungl. Development of Molecules Antagonizing Heparan Sulfate ProteoglycansSeminars in Thrombosis and Hemostasis 2021; 47(03): 316 doi: 10.1055/s-0041-1725067
14
Yujiao Zhou, Feifei Liu, Chengmin Li, Guo Shi, Xiaolei Xu, Xue Luo, Yuanling Zhang, Jingjie Fu, Aizhong Zeng, Limin Chen. Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular CarcinomaJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/9832467
15
Hsiang-chi Tseng, Wei Xiong, Saiaditya Badeti, Yan Yang, Minh Ma, Ting Liu, Carlos A. Ramos, Gianpietro Dotti, Luke Fritzky, Jie-gen Jiang, Qing Yi, James Guarrera, Wei-Xing Zong, Chen Liu, Dongfang Liu. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinomaNature Communications 2020; 11(1) doi: 10.1038/s41467-020-18444-2
16
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(20): 2416-2429 doi: 10.3748/wjg.v25.i20.2416
17
Dan Chen, Xiaoting Li, Hui Li, Kai Wang, Xianghua Tian, Jimei Wang. Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular CarcinomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5313149
18
Changpei Cheng, Qiyang Shou, Jiali Lang, Lu Jin, Xia Liu, Dongxin Tang, Zhu Yang, Huiying Fu. Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression MicroenvironmentFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00809
19
Rebekka Bent, Lorna Moll, Stephan Grabbe, Matthias Bros. Interleukin-1 Beta—A Friend or Foe in Malignancies?International Journal of Molecular Sciences 2018; 19(8): 2155 doi: 10.3390/ijms19082155
20
Carina Hage, Sabine Hoves, Mailin Ashoff, Veronika Schandl, Stefan Hört, Natascha Rieder, Christian Heichinger, Marco Berrera, Carola H. Ries, Fabian Kiessling, Thomas Pöschinger, Roger Chammas. Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapyPLOS ONE 2019; 14(7): e0219517 doi: 10.1371/journal.pone.0219517
21
Min Yao, Wenli Sai, Wenjie Zheng, Li Wang, Zhizhen Dong, Dengfu Yao. Secretory Clusterin as a Novel Molecular-targeted Therapy for Inhibiting Hepatocellular Carcinoma GrowthCurrent Medicinal Chemistry 2020; 27(20): 3290 doi: 10.2174/0929867326666190624161158
22
Dan Peng, Yongqing Cai, Geng Chen, Min Hou, Xiaofeng Luo, Zhuoma Dongzhi, Hongjun Xie, Yao Liu. Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysisFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1101063
23
Ananya Ajith, Makram Merimi, Mandana Kazem Arki, Nikoo Hossein-khannazer, Mehdi Najar, Massoud Vosough, Etienne Marc Sokal, Mustapha Najimi. Immune regulation and therapeutic application of T regulatory cells in liver diseasesFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1371089
24
Qingjia Chi, Di Wang, Ting Sun, Hua-Ping Liang. Integrated bioinformatical and in vitro study on drug targets for liver cirrhosis based on unsupervised consensus clustering and immune cell infiltrationFrontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.909668
25
Jingyu Xiao, Fei Wang, Xiaoyan Hu, Dongli Li, Geng Liu, Qumiao Xu, Chao Chen, Haitao Xiang, Xuan Dong, Linnan Zhu, Dishuang Yang, Yanan Gao, Meijuan Wang, Yonglun Luo, Cheng‐Chi Chao, Guanglei Li, Qiongyu Guo. Engineering In Vitro Organ‐Structured Tumor Model for Evaluating Neoantigen‐Specific T Cell Responses in Hepatocellular CarcinomaAdvanced Materials Interfaces 2023; 10(24) doi: 10.1002/admi.202300155